Ocugen is trading at $0.82, down 5.49%, on October 15, 2026, amid broader market pressure following hotter-than-expected U.S. inflation.
- Supplied market context also reports sharp declines in Asian markets and weaker Nasdaq futures, consistent with defensive sentiment toward growth stocks.
- Ocugen announced an OCU400 licensing deal for the MENA region, but reporting does not establish it as the cause; no clear company-specific catalyst was found.